home.social

#clinicaltrials — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #clinicaltrials, aggregated by home.social.

  1. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  2. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  3. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  4. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  5. Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

    The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

    justpaste.in/news/enveda-secur

    #clinicaltrials #Enveda #InBrief #AI #BiotechampHealth

  6. This Startup Is Using #AI to Fight Off a Future AI #Pandemic
    #RedQueenBio is using #artificialintelligence to design #antibody #drugs for novel pathogens—before future AI systems create them
    The company, in which OpenAI is a lead investor, says it has raised $36 million. Human #clinicaltrials of their antibody drugs against bird flu and other viruses in the flu family are planned for next year.
    wsj.com/health/this-startup-is
    archive.is/20260928010231/http